0001209191-22-012915.txt : 20220224
0001209191-22-012915.hdr.sgml : 20220224
20220224204657
ACCESSION NUMBER: 0001209191-22-012915
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220222
FILED AS OF DATE: 20220224
DATE AS OF CHANGE: 20220224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jain Rita
CENTRAL INDEX KEY: 0001707797
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35420
FILM NUMBER: 22673940
MAIL ADDRESS:
STREET 1: C/O AKEBIA THERAPEUTICS, INC.
STREET 2: 245 FIRST STREET, SUITE 1100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChemoCentryx, Inc.
CENTRAL INDEX KEY: 0001340652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943254365
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 835 INDUSTRIAL ROAD
STREET 2: SUITE 600
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-210-2900
MAIL ADDRESS:
STREET 1: 835 INDUSTRIAL ROAD
STREET 2: SUITE 600
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-22
0
0001340652
ChemoCentryx, Inc.
CCXI
0001707797
Jain Rita
C/O CHEMOCENTRYX, INC.
835 INDUSTRIAL ROAD, SUITE 600
SAN CARLOS
CA
94070
1
1
0
0
EVP, Chief Medical Officer
Restricted Stock Units
2022-02-22
4
A
0
11600
A
Common Stock
11600
11600
D
Stock Option (right to buy)
29.83
2022-02-22
4
A
0
14700
A
2032-02-22
Common Stock
14700
14700
D
Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
The restricted stock units awarded on February 22, 2022, vests in four equal installments on January 1, 2023, January 1, 2024, January 1, 2025, and January 1, 2026, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.
The option was granted on February 22, 2022, and 25% of the total number of shares of common stock subject to the option vests on January 1, 2023, and 1/48th of the total number of shares of common stock subject to the option vests monthly thereafter, subject to the Reporting Person's continued service to the Company on each such vesting date.
Not applicable.
/s/ Susan M. Kanaya, as Attorney-in-Fact
2022-02-24